Skip to main content
Stock Expert AI
Momentum Movers INTERMEDIATE ✨ AI Enhanced

Cerebras stock rose after a report with a raised outlook

4 min read Data as of 3 sources
CBRS$108.72+11.22%

AI-generated editorial content. For informational purposes only. Not financial advice.

The Take

  • Cerebras Systems (CBRS): Two-session gain. Cerebras shares rose 7.56% through Nov. 13, 2026, after the company's third-quarter report on Nov. 12.
  • Mixed results. Revenue beat the analyst estimate, but the per-share loss was far wider than analysts expected.
  • What's next. Management said the cloud ramp begins in December, with the Microsoft deal details due in the first half of 2027.
  • -0.67 vs -0.15455EPS vs estimateAs of
  • $230.9M vs $214.7MRevenue vs estimateAs of
  • 108.72 USDShare priceAs of
  • 11.22%Day changeAs of
CBRS — Journal cover

Stock Expert AI data cover: figures from Financial Modeling Prep. Photo credit and licence on the image

Cerebras (CBRS) shares gained 7.56% over two sessions through Nov. 13, 2026. The stock traded at 108.72 USD on the latest quote that day, up 11.22% on the day.

The move followed the company's third-quarter report on Nov. 12. Revenue beat the analyst estimate, but the loss per share was much wider than expected.

What moved it

According to the company's earnings call on Nov. 12, Cerebras exceeded all of its guided business metrics. CEO Andrew Feldman said so directly, and CFO Robert Komin said demand continues to outpace supply by a wide margin.

The company also raised its outlook. It now expects fourth-quarter core revenue of $310M to $330M, according to its guidance. Management said it expects revenue to triple in 2027. The sources do not tie the share move to the raised outlook; the shares rose after a report that included it.

Management named new hyperscaler wins, meaning large cloud providers, including AWS, Oracle and Microsoft. Two articles followed on Nov. 14, one from MarketBeat and one from a Seeking Alpha contributor who upgraded the stock. Both came after the Nov. 13 quote.

What the numbers say

For the third quarter ended Sept. 30, 2026, revenue was $230.9M against an analyst estimate of $214.7M, a difference of +$16.2M. That $230.9M matches the company's non-GAAP "core" revenue measure; Komin cited record core revenues. Revenue in the filing was $210.8M, up 55.3% from a year earlier.

The GAAP loss was $0.67 per share against an analyst estimate of a loss of $0.15. Net loss was $161.2M, compared with a net loss of $22.2M a year earlier. Komin said core net income turned positive at $30 million, the company's first positive non-GAAP net income as a public company. That is a non-GAAP measure, and management's figure, not a GAAP result.

The share price sits 71.9% below its 52-week high of 386.34 USD and 39.7% above its 52-week low of 77.84 USD.

Risks the evidence shows

The OpenAI contract is the majority of reported remaining performance obligations (RPO). Feldman said Cerebras is "running behind schedule on initial tranches." On the call, Komin said delay credits were deducted from RPO and that less than 5% of total committed megawatts could be subject to cancellation this year. Management projects being back on schedule by the second half of 2027.

Gross margin was 44.6% in Q1 FY2026, 14.2% in Q2 and 20.0% in Q3, per FMP. Among recent Form 4 filings in the last 90 days, there were 19 insider sales and no open-market purchases.

What to watch next

  • December 2026: Komin said data center capacity begins to ramp, which he called too late to affect Q4. He expects flattish sequential cloud revenue in Q4, with the bulk of the capacity increase starting in the middle of 2027.
  • First half of 2027: Feldman said details of the Microsoft deal will come then.
  • Early summer 2027: Feldman said the next-generation CS-5 system ships.

Key facts

  • Nov. 12, 2026: Cerebras reported third-quarter results, with revenue above the analyst estimate.
  • Nov. 13, 2026: the stock traded at 108.72 USD on the latest quote, up 11.22% on the day.
  • Sept. 30, 2026: cash and short-term investments were $7.36B and total debt was $1.45B. FMP lists net debt of -$1.62B.
  • Third quarter: free cash flow was -$838.6M, as capital spending rose.
  • In the latest data: analysts hold nine ratings, all Buy. Their average price target is 253.63 USD, with a range of 170.00 USD to 330.00 USD.
MetricQ3 FY2026Q3 FY2025
Revenue$210.8M$135.7M
Operating income-$224.1M-$26.5M
Net income-$161.2M-$22.2M
Diluted EPS-0.67-0.1

Frequently asked questions

Q: Why did Cerebras stock rise?

Shares gained 7.56% over two sessions through Nov. 13, 2026, after the Nov. 12 report, in which the company said it exceeded its guided metrics and raised its outlook. The sources do not say what drove the move.

Q: Did Cerebras make a profit in the third quarter?

No. It lost $0.67 per share in the quarter ended Sept. 30, 2026, against an analyst estimate of a loss of $0.15. Revenue beat the estimate. Management said non-GAAP core net income was positive.

Q: What risks did Cerebras name?

Management cited data center delays (land, power and shell), OpenAI delay credits and possible U.S. policy challenges for data center development. Feldman presented memory shortages as an opportunity for Cerebras, which does not use HBM, and a cost problem for competitors. Komin said data center capacity begins to ramp in December, too late to affect Q4.

This is educational content, not investment advice. Past performance does not guarantee future results.

CBRS on Stock Expert AI

A 0-100 score built from five sections.

🎯

MoonshotScore AI Ratings

Each stock is scored 0-100 on five pillars: Business Quality, Financial Safety, Valuation, Growth Durability and Momentum. A story quotes the score of the day it was written.

CBRS AI Rating

Related Tickers

earningstechnologysemiconductors

Sources

Related Sectors & Industries

Next story

Biotech Brief Novo Nordisk beat EPS estimates by 21.8%. Its margin still slipped. 4 min readNVO
👁 Editorial Transparency
🧠Content generated by AI editorial engine
👤Stock Expert AI Research is an AI editorial voice of Stock Expert AI
✅Written by Stock Expert AI's research desk with AI assistance. Figures come from FMP data and the official sources cited in the article.
🛡Financial Modeling Prep (FMP)
🕑Last updated:

Get the week's earnings in one Thursday email

The S&P 500 companies on that week's earnings calendar, each with its current MoonshotScore, plus the week's Journal research. Free, one email a week, with an unsubscribe link in every issue.

We send one confirmation email first and nothing else until you click its link (it works for 7 days). After that, the Weekly only. Your address is not sold or shared. Newsletter details · Free guide: How to read a MoonshotScore · Privacy Policy


Explore More Market Intelligence

Evidence & Sources

  • Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures.
  • MoonshotScore V2 rates eligible US-listed companies from 0 to 100 against their sector peers on five pillars: Business Quality (weight 26), Financial Safety (weight 20), Valuation (weight 18), Growth Durability (weight 16) and Momentum (weight 12). Weights are rescaled to 100 when all five pillars have data: 28.3%, 21.7%, 19.6%, 17.4% and 13.0% of the score. It reads no news-sentiment or analyst data, and it is not a probability of future returns.
  • Definitions follow standard investing terminology, with key terms explained inline in plain language where useful.
  • Each price is the last quote we recorded, shown with the trading session it belongs to. Pages are served from a cache, so the copy you are reading can lag that quote. Each quote is a provider snapshot, not an exchange feed.
  • This page is educational and does not constitute investment advice.
  • Numbers come from market data providers (FMP); AI writes the plain-English explanations around them, which should be verified with independent research.